Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
James Burton, DM, FRCP
Nihar R. Desai, MD, MPH
The Edema Question: Selecting a Potassium Binder in Patients With HF or Congestion
Pauline A. Swift, PhD
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
Ellie Kelepouris, MD, FACP, FAHA
Potassium Binders to Optimize GDMT Therapy in HFrEF
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
Jonathan Barratt, MD, PhD
The Evolving Role of Biomarkers in IgAN
Chee Kay Cheung, MBChB, MRCP, PhD
Unmasking IgAN: Achieving Earlier Diagnosis
An De Vriese, MD, PhD
Translating Evidence into IgAN Care
Jörg Latus, MD
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
CKD-aP Uncovered Prevalence & Pathophysiology
Steven Fishbane, MD
Nancy Helou, PhD
Itching for Answers: Holistic CKD-aP Care
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
What You Don’t See: A Patient’s View of Living with CKD-aP
When Itching Hurts: Quality of Life Disruption in CKD-aP
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD
Julio Núñez, MD, PhD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.